Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new ...

"It has been postulated that the brain's renin-angiotensin-aldosterone system plays a special mediating role in epilepsy ...

Keros will host an update call and webcast today, December 12, 2024, at 8:00 a.m. ET LEXINGTON, Mass., Dec. 12, 2024 (GLOBE ...

For more than 15 years, researchers at the Icahn School of Medicine at Mount Sinai have worked tirelessly to find a solution ...

Knowing that TGF-Beta was capable of unlocking its receptor while bound by LAP, the UCSF scientists suspected that these ...

Endothelial cells are also likely to participate in activation, both by production of cellular fibronectin and via conversion of transforming growth factor (TGF)-beta from the latent to active ...

The TGF-B Targeted Drug Development Summit returns to San Francisco for the 4th year to deep dive into the hottest topics in the field, such as combination strategies being employed by Genentech and ...

clearance from the US Food and Drug Administration (FDA) to enter Phase I clinical trials. Beyond anti-inflammatory ...

With experience in approved TGF-beta drugs Reblozyl and Winrevair, the company is developing drugs optimized for better efficacy and safety, the analyst tells investors in a research note.